Dong X, Michelis M A, Wang J, Bose R, DeLange T, Reeves W H
University of North Carolina at Chapel Hill, 27599-7280, USA.
Arthritis Rheum. 1998 Aug;41(8):1505-10. doi: 10.1002/1529-0131(199808)41:8<1505::AID-ART23>3.0.CO;2-N.
A patient was identified with an unusual autoimmune syndrome consisting of systemic lupus erythematosus and sarcoidosis. Her serum contained extremely high levels of autoantibodies to the DEK protooncogene product. The patient's serum was used to clone a dek complementary DNA, which was expressed as a histidine-tagged fusion protein in Escherichia coli. Using affinity-purified recombinant DEK protein, anti-DEK autoantibodies were found in the patient's serum at a titer of 1:10(6) by enzyme-linked immunosorbent assay (ELISA). Longitudinal studies revealed marked variations in anti-DEK autoantibody levels over time. Although it has been suggested that anti-DEK autoantibodies are a marker for pauciarticular juvenile rheumatoid arthritis with iridocyclitis, the present data suggest that they may be associated with other disease subsets as well. The quantitative ELISA technique will be useful for defining these subsets further and for examining the relationship between anti-DEK titers and disease activity.
一名患者被诊断患有由系统性红斑狼疮和结节病组成的罕见自身免疫综合征。她的血清中含有极高水平的针对DEK原癌基因产物的自身抗体。用该患者的血清克隆了dek互补DNA,并在大肠杆菌中表达为组氨酸标签融合蛋白。通过酶联免疫吸附测定(ELISA),使用亲和纯化的重组DEK蛋白,在患者血清中发现抗DEK自身抗体的效价为1:10(6)。纵向研究显示抗DEK自身抗体水平随时间有显著变化。虽然有人提出抗DEK自身抗体是伴有虹膜睫状体炎的少关节型幼年类风湿关节炎的标志物,但目前的数据表明它们也可能与其他疾病亚组有关。定量ELISA技术将有助于进一步界定这些亚组,并研究抗DEK效价与疾病活动之间的关系。